The U.S. Food items and Drug Administration alerted brand-title and generic companies June 18 a couple of exploration business in India that had falsified the info Employed in important reports to get approval of its drugs."I believe it raises a lot of questions on the implications for the medicine available on the market," reported Massoud Motamed